Publications by authors named "Sherahe Fitzpatrick"

Claim this Profile
O
One-year efficacy and safety study of a 1.62% testosterone gel in hypogonadal men: results of a 182-day open-label extension of a 6-month double-blind study.
Joel M Kaufman, Michael G Miller, Sherahe Fitzpatrick, Cecilia McWhirter, John J Brennan

J Sex Med· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of skin washing on systemic absorption of testosterone in hypogonadal males after administration of 1.62% testosterone gel.
Jodi Stahlman, Margaret Britto, Sherahe Fitzpatrick, Cecilia McWhirter, Samuel A Testino

Curr Med Res Opin· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of application site, clothing barrier, and application site washing on testosterone transfer with a 1.62% testosterone gel.
Jodi Stahlman, Margaret Britto, Sherahe Fitzpatrick, Cecilia McWhirter, Samuel A Testino

Curr Med Res Opin· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum testosterone levels in non-dosed females after secondary exposure to 1.62% testosterone gel: effects of clothing barrier on testosterone absorption.
Jodi Stahlman, Margaret Britto, Sherahe Fitzpatrick, Cecilia McWhirter, Samuel A Testino

Curr Med Res Opin· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and relative bioavailability of absorbed testosterone after administration of a 1.62% testosterone gel to different application sites in men with hypogonadism.
Jodi Miller, Margaret Britto, Sherahe Fitzpatrick, Cecilia McWhirter, Samuel A Testino

Endocr Pract· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men.
Joel M Kaufman, Michael G Miller, Jeffrey L Garwin, Sherahe Fitzpatrick, Cecilia McWhirter

J Sex Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experience.
Stanley J Szefler, Ewa Lyzell, Sherahe Fitzpatrick, Mario Cruz-Rivera

Ann Allergy Asthma Immunol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
Kevin R Murphy, Sherahe Fitzpatrick, Mario Cruz-Rivera, Christopher J Miller, Bhash Parasuraman

Pediatrics· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.
Jeffrey G Leflein, Stanley J Szefler, Kevin R Murphy, Sherahe Fitzpatrick, Mario Cruz-Rivera

Pediatrics· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twice-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.
Louis Mendelson, David Cook, Mario Cruz-Rivera, Sherahe Fitzpatrick, Joseph A Smith

J Asthma· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma.
Anne-Marie Irani, Mario Cruz-Rivera, Sherahe Fitzpatrick, Julie Hoag, Joseph A Smith

Ann Allergy Asthma Immunol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis